Anzeige
Meldung des Tages: Ist das DIE Rohstoff-Story des Jahres?

Oramed Pharmaceuticals Aktie News

Aktie
WKN:  A1CTNU ISIN:  US68403P2039 US-Symbol:  ORMP Branche:  Biotechnologie Land:  USA
2,935 €
-0,012 €
-0,41%
09:13:28 Uhr
Depot/Watchlist
Marktkapitalisierung *
102,37 Mio. €
Streubesitz
68,19%
KGV
2,18
Dividende
0,25 $
Dividendenrendite
7,14%
Index-Zuordnung
-

Oramed Pharmaceuticals News

13.01.26 - PR Newswire
Oramed and Lifeward Announce Strategic Transaction
Oramed and Lifeward Announce Strategic Transaction PR Newswire
07.01.26 - PR Newswire
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments PR Newswire
17.11.25 - PR Newswire
Oramed Reports Fiscal Third Quarter 2025 Financial Results
Oramed Reports Fiscal Third Quarter 2025 Financial Results PR Newswire
17.11.25 - PR Newswire
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS PR Newswire
10.11.25 - inv3st.de
Patientenwohl als Schlüssel zu Rendite: Oramed Pharmaceutials, Roche, BioNxt
Höher, schneller, weiter - nicht nur im Sport kommt es auf ständigen Fortschritt an. Auch in Wirtschaft und Wissenschaft geht es um stete Innovationen und Verbesserungen. Die ...
23.10.25 - PR Newswire
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives PR Newswire
28.04.25 - PR Newswire
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical PR Newswire
04.03.25 - PR Newswire
Oramed Pharmaceuticals Issues Letter to Shareholders
Oramed Pharmaceuticals Issues Letter to Shareholders PR Newswire
11.02.25 - PR Newswire
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin PR Newswire
02.02.25 - Boersia.de
Oramed Aktie: Unerwarteter Rückschlag!
Die Oramed Pharmaceuticals Aktie bewegt sich Anfang Februar 2025 in einem herausfordernden Marktumfeld. Mit einer aktuellen Marktkapitalisierung von 86,9 Millionen Euro und ...

Newssuche

Videos

newspaper
20.01.26 +3,87%
Technical Trading: Gold Zukauf
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »